Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Symbiosis00:58

Symbiosis

27.4K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
27.4K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

2.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.9K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

270
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
270
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites.

JAMA network open·2026
Same author

Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical Response.

Open forum infectious diseases·2026
Same author

Frequency and Duration of Diagnostic Delays Associated with Coccidioidomycosis and Risk Factors for Missed Diagnoses, United States.

Emerging infectious diseases·2026
Same author

International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

De novo belatacept-based immunosuppression is not associated with increased risk of invasive fungal infection in kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016-2024.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

11.9K

Histoplasmosis.

Emily M Eichenberger1, Jessica S Little2, John W Baddley3

  • 1Division of Infectious Disease, Department of Medicine, Emory School of Medicine, Atlanta, GA, USA.

Infectious Disease Clinics of North America
|December 19, 2024
PubMed
Summary
This summary is machine-generated.

This review updates knowledge on histoplasmosis, a fungal infection. It covers epidemiology, pathogenesis, diagnosis, and management in both immunocompetent and immunocompromised individuals.

Keywords:
Dimorphic fungiEndemic mycosisHistoplasma capsulatumHistoplasmosisItraconazole

More Related Videos

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
09:56

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

16.2K
Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 4, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

11.9K
Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
09:56

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

16.2K
Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.2K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Histoplasmosis is a significant systemic fungal infection caused by Histoplasma capsulatum.
  • Understanding its epidemiology and clinical spectrum is crucial for effective public health strategies.

Purpose of the Study:

  • To provide a comprehensive update on histoplasmosis.
  • To detail current knowledge on epidemiology, pathogenesis, clinical presentations, diagnostics, and management.

Main Methods:

  • Literature review of recent studies on histoplasmosis.
  • Synthesis of information on changing epidemiological trends.
  • Analysis of diagnostic advancements and therapeutic strategies.

Main Results:

  • Epidemiology of histoplasmosis is evolving globally.
  • Diverse clinical manifestations occur in immunocompetent and immunocompromised hosts.
  • Updated diagnostic and management guidelines are essential.

Conclusions:

  • A current understanding of histoplasmosis is vital for clinicians and public health officials.
  • Tailored management strategies are necessary for different patient populations.
  • Continued surveillance and research are important for controlling histoplasmosis.